Beese Fulmer Investment Management »

Alnylam Pharmaceuticals shares owned by Beese Fulmer Investment Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Beese Fulmer Investment Management from 13F filings

Historical chart of Beese Fulmer Investment Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Beese Fulmer Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Beese Fulmer Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $353k 888 397.65